David R. Liu | |||||||||
|---|---|---|---|---|---|---|---|---|---|
 Liu in 2012 | |||||||||
| Born | June 12, 1973 Riverside, California, U.S. | ||||||||
| Alma mater | Harvard University (BA) University of California, Berkeley (PhD) | ||||||||
| Organization | The Liu Group | ||||||||
| Known for | |||||||||
| Scientific career | |||||||||
| Fields | Organic chemistry | ||||||||
| Institutions | Harvard University | ||||||||
| Doctoral advisor | Peter G. Schultz | ||||||||
| Other academic advisors | E.J. Corey | ||||||||
| Chinese name | |||||||||
| Traditional Chinese | 劉如謙 | ||||||||
| |||||||||
David Ruchien Liu (born 1973) is an American molecular biologist and chemist. He is the Richard Merkin Professor, Director of the Merkin Institute of Transformative Technologies in Healthcare, and Vice-Chair of the Faculty at the Broad Institute of Harvard and MIT; Thomas Dudley Cabot Professor of the Natural Sciences and Professor of Chemistry and Chemical Biology at Harvard University; and Howard Hughes Medical Institute Investigator.[1]
- ^ "David R. Liu". Liu Group. 2018-10-22. Retrieved 2019-04-02.